Shalini , K. et al. 2024. To Assess the Efficacy and Safety of Fixed-Dose Combination of Teneligliptin and Pioglitazone (Tiban P) in Iraqi Patients with Type 2 Diabetes Mellitus. International Journal of Research in Pharmacy and Life Sciences. 12, 02 (Aug. 2024), 31–37. DOI:https://doi.org/10.30904/j.ijrpls.2024.4722.